| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
|---|
| Research Abstract |
We identified plectin as a promising prognostic biomarker in head and neck squamous cell carcinoma (HNSCC) using proteomic technics and functional studies implied that a decreased expression of plectin suppresses the proliferation,migration and invasion of HNSCC cells. Furthermore, the survival rate of patients with high plectin was significantly lower than that of patients with low E-cadherin levels, which is known to correlate with the poor prognosis of HNSCC.
|
